Terminated PHASE4 INTERVENTIONAL 2-arm NCT02152514

RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo

Randomized Controlled Trial Comparing Post-VATS Analgesia Between Patients With an Intrathecal Injection of Morphine and Sufentanil Versus Placebo.

Sponsor: Université de Sherbrooke

Conditions Morphine Postoperative Pain Rachianesthesia Sufentanil Thoracic Surgery, Video-assisted

Interventions Intrathecal Morphine/Sufentanil PCA

Updated 5 times since 2017 Last updated: Jan 18, 2016 Started: Apr 30, 2013 Primary completion: May 31, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to technical details recruitment was unreasonably slow

Other terminated trials from Université de Sherbrooke

See all terminations from Université de Sherbrooke

Listed as NCT02152514, this PHASE4 trial focuses on Morphine and Postoperative Pain and remains terminated or withdrawn. Sponsored by Université de Sherbrooke, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Université de Sherbrooke

Data source: Université de Sherbrooke

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sherbrooke, Canada